WHO/IGWG

Official executive summary of the report of the WHO Expert Working Group on Research and Development Financing

23 December 2009

The Official Executive Summary and Recommendations of the Report of the Expert Working Group on Research and Development Financing to the Executive Board has been published on the website of the WHO Executive Board as document EB126/6 Add.1. It has a provisional agenda item number of 4.3. The official WHO link to this Executive Summary is: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_6Add1-en.pdf

KEI Comments to EWG 2nd Web-based Public Hearing: Defending the Status Quo, or Roadmap for Change?

On Saturday, KEI filed comments with the WHO EWG's 2nd web based hearing. Our comments focused on the criteria for new proposals.

KEI comments to IGWG2

Written by Judit Rius Sanjuan
Friday, 09 November 2007

KEI comments to IGWG2

8 November 2007

KEI appreciates the opportunity to speak today. Our comments will focus on 3 items.

1. Transparency

WHO IGWG (Spanish)

Written by Judit Rius Sanjuan
Wednesday, 23 May 2007


Informe de KEI

Comments on the IGWG II bis

Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International 

Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines

Nicoletta Dentico, Policy and Advocacy Advisor, DNDi

Margaret Chan on “new initiatives, and new incentive schemes”

At the WIPO Conference on Intellectual Property and Public Policy Issues today, Margaret Chan, the Director General of the World Health Organization, made the following speech at WIPO’s Conference on Intellectual Property and Public Policy Issues on the topic of “Strengthening Multilateral Cooperation on IP and Public Health” where she shared the limelight with Pascal Lamy, Director General of the World Trade Organ

WHO releases sketchy report on second meeting of Expert Working Group on R&D Financing

The World Health Organization just published a report on this week’s second meeting of the WHO Expert Working Group (EWG) on R&D Financing.

Civil Society letter to Members of the WHO Expert Working Group on R&D Financing

Today nine NGOs sent a letter the WHO Expert Working Group on R&D Financing. The letter focuses on issues about transparency, conflicts of interest, and EWG outcomes. The whole EWG seems to be going very badly right now, in part because of the US government and much of Northern Europe is working hand and glove with the pharmaceutical industry, and partly because the Gates Foundation is protecting big pharma and seems to have an ideological attachment to strong IPR.

Syndicate content